CD31 is currently the single best marker of endothelial differentiation and is expressed in 90% of hemangiosarcomas, hemangioendotheliomas, hemangiomas, and Kaposi’s sarcomas (Handra-Luca, 2019; Venkataramani et al., 2018). This evidence concerns the gene PECAM1 and Kaposi's sarcoma.